Ascentage Pharma Group International American Depository Shares (AAPG) vs City Therapeutics (CTY)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Ascentage Pharma Group International American Depository Shares is the larger company by market cap ($1.12 billion vs $1.03 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AAPG | CTY |
|---|---|---|
| Share price | $11.97 | $19.32 |
| Market cap | $1.12B | $1.03B |
| 1-day change | -3.78% | +5.29% |
| YTD return | -54.38% | — |
| 1-year return | -60.93% | — |
| EPS (TTM) | $-2.26 | $-2.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $134.35M | — |
| Net income (latest FY) | $-55.54M | — |
| Gross margin | 97.03% | — |
| Net margin | -41.34% | — |
| 52-week high | $33.09 | $23.88 |
| 52-week low | $11.97 | $15.81 |
| Distance from 52-week high | -63.83% | -19.10% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +271.76% | +93.22% |
| Average volume | 6.97K | 328.87K |
| Shares outstanding | 93.33M | 53.39M |
| Employees | 828 | 75 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Ascentage Pharma Group International American Depository Shares
AAPG stock →Ascentage Pharma Group International, a clinical-stage biotechnology company, develops therapies for cancers, chronic hepatitis B virus (HBV), and age-related diseases in Mainland China. The company's primary product candidate is HQP1351, a BCR-ABL inhibitor targeting BCR-ABL1 mutants, including those with the T315I mutation.
Health Care · Biotechnology: Pharmaceutical Preparations · 828 employees
About City Therapeutics
CTY stock →City Therapeutics, Inc. operates as a biopharmaceutical company focused on developing RNA interference (RNAi)-based medicines by engineering RNAi trigger molecules.
Health Care · Biotechnology: Pharmaceutical Preparations · 75 employees
AAPG vs CTY FAQ
Which is bigger, Ascentage Pharma Group International American Depository Shares or City Therapeutics?
Ascentage Pharma Group International American Depository Shares (AAPG) is larger, with a market capitalization of $1.12B compared with $1.03B for City Therapeutics (CTY).
Are Ascentage Pharma Group International American Depository Shares and City Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.